Healthcare
Sotera Health Company(SHC)
Live Price
Offline$16.19
-1.22% today
1Y Change
+35.73%
Window
Jun 20, 2025 โ Jun 17, 2026
- Market Cap
- $4.42B
- Revenue Growth
- +5.7%
- EPS Growth
- +68.8%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 20, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sotera Health Company (SHC) is a Healthcare stock with a market cap of $4.42B and listed on NASDAQ. The stock last traded around $16.19 and up 35.7% across the available one-year price window (Jun 20, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +5.7%, EPS growth of +68.8%, a dividend yield of 0.0%. What stands out right now is revenue +5.7%, EPS +68.8%, free cash flow +230.8% with operating margin 33.8% and ROIC 6.8%. Valuation already assumes a fairly strong business story at P/E 56.5 and price/sales 3.8. Stock Foundry combines SHC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+5.7% vs +7.6% peer median
Operating Margin
Above sector median
+33.8% vs +19.4% peer median
P/E
Above sector median
56.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5.7% and EPS at +68.8%, with operating margin around 33.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +0.7% | -1.1% | -0.3% |
2026 Feb 24, 2026 | +8.3% | -3.3% | -6.1% | -17.3% |
2025 Nov 4, 2025 | +18.2% | -3.8% | -1.8% | +2.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SHC Max Drawdown
-32.14%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SHC and SPY.
Company Overview
Sotera Health Company
NASDAQ Global Select
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
- Leadership
- Michael Petras Jr.
- IPO Date
- Nov 20, 2020
- Employees
- 3.0k
- Street Address
- 9100 South Hills Boulevard
- Mailing
- Broadview Heights, OH, 44147
- Region
- Broadview Heights, OH, US
- Reporting Currency
- USD
- Investor Line
- 440 262 1410
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 56.5
- EV/EBITDA
- 14.2
- Price/Sales
- 3.8
- Price/Book
- 7.3
Growth
- Revenue
- +5.7%
- EPS
- +68.8%
- Free Cash Flow
- +230.8%
Profitability
- Gross Margin
- 55.5%
- Operating Margin
- 33.8%
- Net Margin
- 6.7%
- ROE
- 15.0%
- ROIC
- 6.8%
Balance Sheet
- Debt/Equity
- 3.75
- Current Ratio
- 2.46
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.